Full Press Release Details
IDEAYA Biosciences Announces US FDA IND Clearance for IDE849, a Potential First in Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors.
IDYA
IDEAYA Biosciences Announces US FDA IND Clearance for IDE849, a Potential First in Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors
Key Takeaway: IDEAYA Biosciences Announces US FDA IND Clearance for IDE849, a Potential First in Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors